Global Sinus Therapeutic Drug Market By Drug Class, By Disease Type,By Route of Administration, By Distribution Channel, By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

Sinusitis is one of the most common upper respiratory tract infections. Rhino-sinusitis is classified into acute and chronic according to severity and nature. It has been observed that most cases of acute sinusitis are caused by viral infections and the common cold. Most cases of sinusitis use congestion, painkillers, and saline flushes, especially in patients with remission of symptoms. There are three main types of sinusitis namely: acute sinusitis, subacute sinusitis, and chronic sinusitis. Acute sinusitis also is known as acute infectious sinusitis that lasts less than 30 days, while chronic sinusitis lasts more than 3 months. Sinus infection can be diagnosed by physical inspection of the characteristics of the nasal mucosa, the presence of polyps, and the structure of the nasal septum. Imaging procedures such as ultrasound, Magnetic Resonance Imaging (MRI), computed tomography (CT) and ultrasound can also be used to diagnose sinus infections.

According to a survey by Sinuwave Technologies Corporation, sinusitis affects 40% of the US population, with annual treatment expenditures of approximately US$ 8.6 billion. According to medical experts, acute sinusitis is usually caused by a virus, and patients need auxiliary treatment such as nasal irrigation. In the case of chronic sinusitis, patients should be treated with multiple antibiotics, local and systemic glucocorticoid therapy, and other medications. Treatments for sinusitis include the use of painkillers, antihistamines, corticosteroids, antibiotics, sulfonamides, and surgery. Antibiotics that are used to treat bacterial sinusitis include macrolides, penicillin, and cephalosporin’s. The most mutual corticosteroids in sinusitis are mometasone, fluticasone, triamcinolone and prednisone. Sulfa drugs that are used to treat sinus bacterial infections include sulfamethoxazole and trimethoprim. For patients with chronic sinusitis, surgery may be the last option. Two surgical methods for sinus infections are balloon sinusplasty and endoscopy.

The key factors leading to the market growth are front-line actions for non-communicable sinusitis, upcoming new drug delivery technologies, and increasing patient awareness to help increase the rate of disease diagnosis. During the forecast period, the antibiotics segment is expected to witness high growth due to the development of diagnostic technologies after the introduction of rapid microbiological tests, the widespread use of antibiotics in infection treatment, and the increasing prevalence of bacterial infections. Rapid penetration of market participants seeking growth opportunities in Asia Pacific markets such as India, China, Philippines, Indonesia is also increasing. Rising air pollution levels worldwide is one of the major causes of sinusitis. In recent years, breakthrough medical technologies have led to the introduction of balloon ostomy and drug-eluting sinus stents. Other emerging options for the treatment of sinusitis include adjuvant treatments such as antifungals, anti-IgE, anti-IL5, capsaicin, and bacterial lysates.

North America dominates the market for sinusitis treatment medications due to rising prevalence of sinusitis, advanced diagnostic technologies, and a high level of understanding of the disease among patients and medical professionals. The Asia-Pacific region is expected to register the fastest-growing region due to increasing awareness of patients’ sinus diseases.

Based on the Drug Class, it can be classified into:

• Analgesics
• Antihistamines
• Corticosteroids
• Antibiotics
• Sulphonamides
• Other Drug Classes

Based on the Disease Type it can be further segmented into:

• Acute sinusitis
• Sub-acute sinusitis
• Chronic sinusitis

Based on the Route of Administration it can be classified as:

• Topical
• Oral
• Injectable

Based on the Distribution Channel, it can be further classified into:

• Retail Pharmacies
• Online Pharmacies
• Ambulatory Care Center
• Hospital Pharmacies
• Other Distribution Channels

Key Players in the market are:

• Novartis AG
• Sun Pharmaceutical Industries, Inc.
• Reddy’s Laboratories, Inc.
• Tea Pharmaceutical Industries Ltd.
• Fresenius Kabi USA
• Johnson & Johnson
• Pfizer Inc.
• Janssen Pharmaceuticals, Inc.

For the Sinus Therapeutic Drug Market research study, the following years have been considered to estimate the market size: